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Abstract
Objectives: The aims of this study were to assess potentially inappropriate medications (PIMs)
or Beers medications among outpatient older adults within one Midwestern healthcare system, to
determine rates of patient education on Beers medications, and to pilot an educational
intervention for providers.
Methods: This study involved two parts. For part 1 of the study, a randomized retrospective
chart review of 493 older adult patients seen in 2017 from four practices was conducted to assess
Beers medication prescriptions and rates of patient education. Following the chart review, for
part 2 of the study, an educational intervention was delivered to two providers at one practice site
on the Beers Criteria and chart review results. A post-test only design was used to determine
intervention success.
Results: Of the patients included, 64.2% (n = 316) were prescribed a Beers medication during
2017. There were no statistically significant differences for age, gender, or race. A total of 50
different Beers medications were prescribed. The most frequently prescribed drug categories
included Proton-pump inhibitors (25.1%), Non-steroidal anti-inflammatory drugs or NSAIDS
(18.2%), Benzodiazepines (16%), Anticholinergics (13.6%), and Skeletal muscle relaxants
(8.2%). The rate of documented patient education on the risks of the Beers medication(s) was
11.4% (n = 36). Both of the providers who participated in the educational session demonstrated
100% proficiency on the post-test.
Conclusion: This study not only demonstrated potentially inappropriate medication prescription
trends but also identified a gap in these prescriptions and patient education on the risks
associated with the medications. An educational session for providers demonstrated great
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potential for refreshing memories and/or providing new information on the Beers Criteria and the
importance of patient education.
Keywords: older adults, potentially inappropriate medications, Beers Criteria, provider
education
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An Assessment of Potentially Inappropriate Medications Among the Elderly and the Effect of an
Educational Intervention on Provider Knowledge of These Medications
Introduction
The elderly or “older adult” population in the United States is predicted to increase
dramatically over the next several years, reaching an estimated 83.7 million by 2050 (Ortman,
Velkoff, & Hogan, 2014). Just as this special population is growing, so is the concern for
providing appropriate evidence-based care. Due to having more than one disease process, older
adults are complicated utilizers of the healthcare system and pharmacotherapy (Wooten, 2012).
Pharmacokinetic changes that take place in these individuals can cause them to respond
differently to medications than the younger population, placing them at risk for adverse drug
reactions (Wooten, 2012). Such changes in the body include altered gastric pH and function, an
increased percentage of fat along with a subsequent loss of muscle, and reduced hepatic and
renal function (Wooten, 2012).
A cohort study among over 30,000 Medicare recipients examined the quantity, severity,
and preventability of adverse drug events and identified a total of 1,523 of these events. (Gurwitz
et al., 2003). Approximately 27.6% of adverse drug events were preventable and errors that
correlated with preventable drug reactions occurred most commonly at the prescribing and
monitoring phases of the pharmacotherapy process; therefore, Gurwitz et al. (2003)
recommended interventions that target these specific phases. The Beers Criteria is a tool that
when utilized, targets these exact phases.
The Beers Criteria include lists of potentially inappropriate medications (PIMs) for older
adults over the age of 65 (American Geriatrics Society [AGS] 2015 Beers Criteria Update Expert
Panel, 2015). These lists were originally developed by Dr. Mark Beer, a gerontologist, and have
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been in circulation since 1991 (AGS 2015 Beers Criteria Update Expert Panel, 2015). The
American Geriatrics Society has updated these lists several times, including most recently in
2015. These lists were designed to serve as a guide for providers in promoting medication safety
in the older adult population (AGS 2015 Beers Criteria Update Expert Panel, 2015).
Unfortunately, there is no current intervention within the principle investigator’s
healthcare system that utilizes the Beers Criteria to help providers make decisions when
prescribing to the older adult population. Moreover, a chart review was conducted at one
outpatient practice within the principle investigator’s organization which identified a gap
between Beers medication prescriptions and patient education. This chart review revealed that
out of 101 patients on at least one Beers medication, 196 total Beers medications were prescribed
within a one-year time frame (Parker, 2016). Additionally, only four charts out of the 101 charts
reviewed contained documentation that education was provided to the patient regarding the
potential side effects of the Beers medications (Parker, 2016). The purpose of this study was to
expand the previous chart review done by Parker (2016) to assess Beers medication prescriptions
within the larger healthcare system.
Background
Potentially inappropriate medications or PIMs are medications that providers should
completely refrain from prescribing to patients age 65 and older, prescribe with dosage
adjustments, or prescribe with plans for close monitoring (AGS 2015 Beers Criteria Update
Expert Panel, 2015). Fick, Mion, Beers, and Waller (2008) reported a significant prevalence of
conditions associated with the use of PIMs, including change in consciousness, syncope, sleep
problems, urinary retention and incontinence, dehydration, bradycardia, depression, falls,
fractures, and delirium to name a few. Another study by Stockl, Le, Zhang, and Harada (2010)
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found that participants who received a high risk sedative hypnotic were 22% more likely to
experience a fall or fracture. Stockl, Le, Zhang, and Harada (2010) also found that the use of
PIMs poses a significant financial burden. As an example, the total medical costs were anywhere
from $2,000 to $11,000 higher for individuals who received PIMs when compared to those who
did not (Stockl, Le, Zhang, and Harada, 2010). A more recent study that looked at the long-term
impact of PIMs, found a reduction in mental functioning in women 75 and older who used these
medications (Koyama, 2014).
The Centers for Medicare and Medicaid Services (CMS) have been monitoring the
prescribing trends of high-risk or potentially inappropriate medications among the older adult
population since 2005 (Qato & Trivedi, 2012). In a national study examining Medicare data on
over 6 million patients, it was determined that 21.5% of Medicare beneficiaries received at least
one PIM and 4.8% received more than one PIM (Qato & Trivedi, 2012). Demographics that
predicted the receipt of PIMs included being female, of low income, and Caucasian (Qato &
Trivedi, 2012).
The Beers Criteria can assist providers in engaging patients in their treatment plans and
enabling patients to understand the side effects associated with their medications. These concepts
are supported by Nola Pender’s Health Promotion Model (2011) which served as a framework
for this study. This theory describes factors that influence health-related behaviors (Pender,
2011). The Health Promotion Model includes seven assumptions, one of which describes health
professionals as having the ability to influence patient behavior (Pender, 2011). There are also 13
theoretical propositions, one of which states that patients are more likely to engage in healthpromoting behavior when they are supported and enabled (Pender, 2011).
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Study Goal and Objectives
The goal of this study was to review Beers medication prescriptions at four practice sites
within the principle investigator’s organization and to develop and pilot an educational program
for providers on the high-risk medications listed in the Beers Criteria and organizational trends.
Specifically, provider knowledge of these high risk medications, as well as patient education
were targeted. The aims of the study included: 1. To determine the rate and type of Beers
medications prescribed to older adult patients from four primary care offices within a large
Midwestern metropolitan healthcare system; 2. To determine the rate of patient education among
those for whom Beers medications were prescribed; and 3. To assess provider knowledge of
Beers medications following an educational session at one pilot site.
Methods
Study Permission
Permission for this study was granted by both the organizational review board and the
University of Kentucky Institutional Review Board. Permission was also granted by the
American Geriatrics Society to distribute copies of “A Pocket Guide to the AGS 2015 Beers
Criteria” to providers in attendance at the educational session.
Design, Sample, and Setting
This study consisted of two parts: Part 1: A randomized retrospective chart review of
older adult patients, and Part 2: A post-test only design following an educational intervention.
The retrospective chart review portion of the study included adult patients age 65 and older from
four practice sites spread out geographically within the larger Midwestern metropolitan
healthcare system. The organization is not-for-profit and at the time of the study included five
hospitals, multiple immediate care centers and specialists, and 30 primary care practices. The
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estimated population of the metropolitan city during the time of the study was 621,349 with
13.8% of the population being age 65 and older (U.S. Census Bureau, 2017b). Just prior to the
study, the healthcare system’s primary care offices served a total of 45,473 elderly patients in
2016, which made up 26% of the population seen. The older adult population was the focus of
the retrospective chart review as the Beers lists of potentially inappropriate medications only
pertain to individuals age 65 and older.
For part 2 of the study, one of the practice sites included in the chart review also served
as the pilot site for the educational intervention. Additionally, this practice site was selected for
the educational intervention because it is the same site where a previous chart review was
conducted by Parker (2016) on Beers medications. The practice site had four providers total,
three physicians, and one nurse practitioner. Just prior to the study, the practice site saw a total of
737 elderly patients in a one-year time frame in 2016, and elderly patients made up 33.6% of all
patients seen in the same year.
Subject Recruitment
For part 1 of the study, retrospective data was obtained from the electronic medical
records of patients from the four practice sites. The charts were randomly selected in
collaboration with the healthcare system’s data specialists based on the inclusion criteria.
Inclusion criteria for the chart review were: a) patients age 65 and older, b) patients seen between
January 1, 2017 and December 31, 2017, and c) patients prescribed at least one medication. A
random sampling method was used with the goal of selecting 125 charts from each of the four
facilities to review for a total of 500 charts.
Following the chart review, for part 2 of the study, an educational session on the Beers
medications and current organizational prescribing trends took place at one of the practice sites
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included in the chart review. The session was open to all providers at the practice site. The
providers participated on a voluntary basis with encouragement from the practice manager. The
principle investigator delivered the education to the providers.
Study Procedures
Following the random selection of charts by the healthcare system’s data specialists, a
crosswalk data table was used by the principle investigator to assign each medial record a unique
identification number. This crosswalk table was then stored on a password protected H drive
maintained by the organization. For each medical record, the principle investigator briefly
analyzed the medication list from all visits in 2017 to determine the number and type of Beers
medications prescribed. Only medications from Table 2 of the Beers Criteria, which are
medications that should generally be avoided in all patients, were included. Medication classes
such as Proton-pump inhibitors and Non-steroidal anti-inflammatory drugs (NSAIDS) were
included if evidence of recurrent or long-term use existed as dictated by the Beers Criteria.
Expired prescriptions were excluded. For those patients identified as having a Beers medication
prescribed, the chart received a code of ‘1,’ and the medication(s) was/were recorded. For
patients identified as having no Beers medications prescribed, the chart received a code of ‘0.”
Demographic variables were collected on all patients including: sex (male vs female), age (in
categories), and race (ethnicity: American Indian/Alaska Native, Asian, Black, Hispanic, Native
Hawaiian or Pacifica Islander, White, Other, Or Unknown). All data collected was de-identified
through the use of the unique identification numbers established by the crosswalk table and
transferred to an electronic spreadsheet for analysis. The electronic spreadsheet was stored on the
secured H drive separately from the crosswalk table containing the medical record numbers.
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No further analysis was conducted on charts with a code of ‘0.’ The principle investigator
further analyzed the charts assigned a code of ‘1’ and examined primary care provider progress
notes and after visit summaries within the year 2017 for documentation of patient education on
the side effects or risks of the Beers medication(s). These charts received another code of ‘1’ if
evidence of education was found, or ‘0’ if no evidence of education was found. Any
documentation on side effects or risks associated with the medications, even general statements,
were accepted. The codes for education were transferred onto the electronic spreadsheet.
The educational session for part 2 of the study took place in September 2018 at the pilot
site. Two providers voluntarily participated in the session. Signed informed consents were
obtained from the providers prior to the session. The providers in attendance were given a copy
of “A Pocket Guide to the AGS 2015 Beers Criteria” by the American Geriatrics Society for
reference. The educational session lasted approximately 15 minutes. A written post-test was
administered to the providers following the session to determine success of the program. The
post-test consisted of five multiple choice questions pertaining to the Beers lists and chart review
results and scored on a true/false scale. Success of the program was determined by a score of
80% or higher on the post-test. Two additional questions were collected on the post-test that
were open-ended and prompted providers to report how familiar they were with the Beers
Criteria prior to the educational session and explain whether or not the educational session was
helpful in refreshing their memory and/or providing them with new information.
Data Analysis
Data from the electronic spreadsheet was analyzed with the assistance of a statistician
employed by the University of Kentucky College of Nursing. Frequency distributions were used
to report categorical variables including age, gender, race, prescription of Beers medications, rate
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of patient education, rate of Beers medications prescribed per patient, and rate of Beers
medications prescribed by drug category. Chi-square tests were used to determine differences in
Beers medication prescriptions by gender and race. The Mann-Whitney U test was used to
examine the association between Beers medication prescriptions and age. Chi-square tests were
also used to determine whether there were differences in Beers medication prescriptions and
patient education between the four practices, with post-hoc comparisons used to further analyze
differences in patient education. Statistical significance was determined at a p-value of <0.05.
SPSS software, version 24, was used for analysis.
Results
Part I
Sample characteristics.
A total of 493 charts from the four primary care offices that met criteria were included in
part 1 of the study. Of the patients included, 81% were between 65 and 79 years of age and
55.2% were female. The majority of the sample was white at 84.4% (see Table 1).
Beers medications prescribed.
Of the 493 patients included, 64.2% (n = 316) were prescribed a Beers medication during
2017 from Table 2 of the American Geriatrics Society 2015 Beers Criteria (AGS 2015 Beers
Criteria Update Expert Panel, 2015). A total of 50 different Beers medications were prescribed
(see Appendix A for full list). The number of Beers medications prescribed per patient ranged
from one to eight, with approximately 75% of patients being on one or two medications (see
Table 2). The most frequently prescribed drug categories included Proton-pump inhibitors
(25.1%), Non-steroidal anti-inflammatory drugs or NSAIDS (18.2%), Benzodiazepines (16%),
Anticholinergics (13.6%), and Skeletal muscle relaxants (8.2%) (see Figure 1). There were no
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statistically significant differences for age, gender, or race between those who were prescribed at
least one potentially inappropriate medication and those who were prescribed no potentially
inappropriate medications. There were no statistically significant differences in the rate of Beers
medications prescribed between the four practices.
Patient education.
Of the 316 patients prescribed a Beers medication, 11.4% (n = 36) had documentation
within their medical record that education was provided on the risks of the medication(s). A
statistically significant difference (p < 0.05) was found in the rate of documented provider
education from Practice #2 when compared to each of the other three practices (see Figure 2).
Part II
Provider knowledge.
Both of the providers who participated in the educational session demonstrated 100%
proficiency on the post-test. On the first survey question, both providers stated that they were
“very familiar” with the Beers Criteria prior to the educational session. Both providers also
answered “yes” to the second survey question which asked if the educational session was helpful
in refreshing their memory and/or providing them with new information. One provider further
stated it is “helpful to document the risks and benefits of medications.”
Following the post-test, anecdotal comments were made by the providers that it would be
beneficial for patients to receive education on the Beers Criteria because it is the patients who are
often resistant to making changes in their medication regimens. Additionally, the providers
mentioned that they have noticed that many patients new to the practice are already established
on a Beers medication.
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Discussion
The study findings support the aims of the study by demonstrating which classes of
potentially inappropriate medications are prescribed most frequently to older adult patients
within the healthcare system. This study also found a significant gap between the prescription of
Beers medications and patient education on the risks associated with these medications.
Furthermore, the post-test demonstrated success of an educational program for providers on
Beers medications, supporting the final aim of the study.
Key Findings
The four practices within the study are located in three different counties surrounding the
larger metropolitan city. According to the U.S. Census Bureau (2017a), these counties ranged
from 72.3-96.2% White, 1.2-22% Black, and 48-51.6% Female. These findings are similar to the
sample characteristics in this study.
It is difficult to compare the study findings on the rate of Beers medications prescribed
(64.2%) to findings within the literature. This is due to the literature varying significantly with
the number of Beers medications prescribed to elderly patients depending on the setting, the
methods used, and the version of the Beers Criteria used. In a study by Qato & Trivedi (2012)
the percentage of Medicare patients that received at least one high risk medication in Kentucky
in 2009 was 25.5-30.8%. A more recent study of Beers Criteria medications among military
hospital patients found that 73% of patients were on at least one of these medications on
admission (Osei, Berry-Caban, Haley, & Rhodes-Pope, 2016). Another study on residential care
facility patients found that around 81.4% of participants had been exposed to a PIM within a 1year time frame (Harrison et al., 2018). In the current study, the majority of patients (75%) were
on one or two Beers medications, which is consistent with the previous DNP student’s findings
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within the same organization (Parker, 2016). Parker (2016) found that 76 out of 101 patients
were on one or two Beers medications.
Similar to the rate of Beers medications prescribed, there are some differences among the
classes of Beers medications most frequently prescribed in the literature. Several other studies
have found Anticholinergics and Benzodiazepines to be among the top drug classes prescribed
(Harrison et al., 2018; Osei et al., 2016; Parker, 2016). NSAIDS are also generally high on the
list of most frequently prescribed PIMs (Osei et al., 2016; Parker, 2016) Furthermore, the study
by Harrison et al. (2018) found Proton-pump inhibitors to be the most frequently prescribed drug
class as well as the PIM class that was associated with the highest cost. This finding is likely a
reflection of the version of Beers Criteria used, because proton-pump inhibitors were added to
the 2015 Beers Criteria update (AGS 2015 Beers Criteria Update Expert Panel, 2015).
The literature supports differences in demographics among those who are on a high risk
medication when compared to those who are not. According to Qato and Trivedi (2012),
demographics that predicted the receipt of PIMs included being female, of low income, and
Caucasian (Qato & Trivedi, 2012). This was not found in the current study as there were no
statistically significant differences for age, gender, or race between those who were prescribed at
least one PIM and those who were prescribed no PIMs. This study did not look at income.
The current study does reinforce Parker’s (2016) findings that there is a gap within the
organization when it comes to educating patients on the potential risks of their Beers
medications. Only 11.4% of charts contained documentation of patient education. A post hoc
analysis did find that Practice #2 had a higher rate of education than the other practices which
was attributed to one provider. This rate was still only 24.7%. Parker (2016) found that less than
4% of patients were educated on the risks of their medications; however, her sample was much
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smaller and only from one practice within the organization.
There is little evidence available within the literature regarding educational interventions
with providers on the Beers Criteria. According to the participating providers in the study
however, the educational session was helpful in at least refreshing their memory on the Beers
Criteria. Additionally, the educational session brought awareness to the providers on the most
frequently prescribed Beers medication classes within the system. Ideally, this could lead to a
reduction in the prescription of these medications in the future by these providers. Further studies
are needed on this type of intervention.
Practice Implications
One practice implication related to this study would be the development of an alert
within the electronic medical record that notifies providers when they are prescribing a Beers
medication to their elderly patients. Currently, no such alert exists for ambulatory patients in the
healthcare system involved in the study despite such an alert being supported by the literature. A
study by Peterson et al. (2014) on inpatients instituted a computerized dashboard within the
electronic medical record that flagged individuals with at least one PIM or high anticholinergic
score. A pharmacist reviewed the flagged records and communicated with the treating physician
with outcomes demonstrating that clinicians acted on 31 out of 40 (78%) pharmacist
recommendations (Peterson et al., 2014). A study by Alagiakrishnan et al. (2016) utilized a
computerized decision support tool for primary care providers. Subjective findings included
clinicians recognizing the appropriateness of such a tool despite a modest time burden that did
not disrupt overall workflow (Alagiakrishnan et al., 2016). Approximately 25% of alerts were
overridden with 15% of alerts prompting an evidence check by the provider (Alagiakrishnan et
al., 2016).
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The incorporation of a “smart phrase” by providers describing how they educated their
patient on their Beers medication(s) is another practice implication. The current electronic
medical record system within the organization allows providers to create “smart phrases” or “dot
phrases” which consist of phrases that they commonly utilize when documenting in the
electronic chart. These phrases can be inserted into the providers’ notes so that education to
patients on Beers medications is more efficiently captured.
Finally, standardization of patient education within the healthcare system on Beers
medications is a very important practice implication. The providers who participated in the
education session recognized that patient education is needed on the Beers Criteria. All patients
within the healthcare system receive after visit summaries following office visits. Providers can
select educational material on individual medications to include in these summaries; however, an
option for general education on the Beers Criteria could also be incorporated to ensure that
patients receive instruction on this topic.
Research Implications
Some future research implications include system-wide expansion of the educational
program followed by evaluation. Additionally, further medical record reviews are needed when
updated versions of the Beers Criteria are published. This would allow for provider education to
be updated to reflect changes in prescribing practices.
Limitations
There were several limitations to this study. First, only those medications that are listed in
the Beers Criteria as medications to avoid for all elderly patients (Table 2) were included in the
medical record review. The tables involving potential drug-condition or drug-drug interactions
were excluded. This may have affected the overall rate of Beers medications prescribed in this
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study. Additionally, the Beers Criteria encourages clinician judgement when prescribing PIMs
based on their professional relationships with patients. This clinical judgement could not be
accounted for in the chart review because medical records were not examined for specific
medical conditions and the principle investigator had no professional relationship with the
patients involved. Some of the medications prescribed therefore may have been appropriate for
some of the patients.
This study also relied heavily on the accuracy of patient medication lists. Medications
flagged by medical assistants or the providers as being taken by the patient were included in the
study unless the medications were prescriptions that expired prior to the time period of the study.
If medications lists were not reviewed and updated appropriately, this may have affected the
results of the study.
Furthermore, education that was delivered to patients on their Beers medication(s) prior
to the study period was not captured. Some patients are on Beers medications for many years, so
it is possible that their providers educated them on the risks when these medications were first
prescribed. This may have affected the overall rate of patient education in this study.
Finally, this study is limited by the small sample of providers who participated in the
educational session. Only two out of the four providers at the pilot site volunteered to participate.
This prohibits generalization of post-test findings to other providers and practices.
Conclusion
Due to normal physiological changes, the growing older adult population poses
challenges to the healthcare system and pharmacotherapy (Wooten, 2012). The Beers Criteria
include lists of potentially inappropriate medications (PIMs) for individuals over 65 years of age
and should be utilized by providers when prescribing to this vulnerable population (AGS 2015
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Beers Criteria Update Expert Panel, 2015). This study not only demonstrated inappropriate
medication prescription trends among older adult patients within one large Midwestern
healthcare system, but also identified a gap in Beers prescriptions and patient education on the
risks associated with the medications. Further interventions are needed within the organization to
assist providers and patients in better understanding and applying the Beers Criteria. A pilot
educational program demonstrated great potential for refreshing providers’ memories and/or
providing new information to providers on the Beers Criteria and the importance of patient
education. Further research is needed on the expansion of this type of educational program to
more providers and practices.
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Table 1. Frequency Distributions for Selected Categorical Variables: Primary Care Patients
Over 65 Years of Age (N=493).
n (%)
Age
65-69
70-79
80-89
>90
Gender
Female
Male
Race/ethnicity
White
Black
Other
Prescribed Beers Medication
Yes
No

198 (40.2%)
201 (40.8%)
77 (15.6)
17 (3.4%)
272 (55.2%)
221 (44.8%)
416 (84.4%)
58 (11.8%)
19 (3.8%)
316 (64.2%)
176 (35.8%)

Note. The “Other” racial category includes subjects in the following categories: American
Indian/Alaskan Native, Asian, Hispanic, Other, and Unknown.
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Table 2. Frequency Distributions for Additional Variables: Primary Care Patients Over 65
Years of Age Prescribed a Beers Medication (N=316)
n (%)
Range of Medications
1-2
3-5
6-8
Evidence of Education
Yes
No

236 (74.7%)
77 (24.4%)
3 (0.9%)
36 (11.4%)
280 (88.6%)
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Beers Medications Prescribed by Drug Category
Sulfonylureas, long-duration
Central alpha agonists
Peripheral alpha-1 blockers
Antispasmodics
Antipsychotics
Other
Antidepressants
Nonbenzodiazepine, benzodiazepine…
Skeletal muscle relaxants
Anticholinergics
Benzodiazepines
NSAIDS
Proton-pump inhibitors
0

5

10

15

20

25

30

Percent
Figure 1. Frequency of Total Beers Medications Prescribed by Drug Category
(Note. The “Other” drug category includes the following medications/categories: Amiodarone,
Digoxin, Androgens, Antiparkinsonian, Dronedarone, and Metoclopramide)
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Percent of Education by Practice
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Practice 4

Figure 2. Frequency of Education Provided on Beers Medication(s) by Practice Site
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Appendix A
Frequency of Beers Medications Prescribed (N = 625)
Medication
Omeprazole
Meloxicam
Promethazine
Pantoprazole
Cyclobenzaprine
Alprazolam
Zolpidem
Esomeprazole
Ibuprofen
Hydroxyzine
Naproxen
Diclofenac
Lorazepam
Diazepam
Clonazepam
Amitriptyline
Dicyclomine
Meclizine
Paroxetine
Temazepam
Lansoprazole
Clonidine
Quetiapine
Digoxin
Amiodarone
Doxazosin
Glyburide
Methocarbamol
Brompheniramine
Nabumetone
Metaxalone
Aripiprazole
Testosterone
Diphenhydramine

n (%)
84 (13.4%)
43 (6.9%)
43 (6.9%)
41 (6.6%)
39 (6.2%)
39 (6.2%)
27 (4.3%)
23 (3.7%)
23 (3.7%)
21 (3.4%)
20 (3.2%)
19 (3%)
17 (2.7%)
15 (2.4%)
15 (2.4%)
14 (2.2)
11 (1.8%)
10 (1.6%)
10 (1.6%)
9 (1.4%)
9 (1.4%)
8 (1.3%)
7 (1.1%)
6 (1%)
6 (1%)
6 (1%
6 (1%)
5 (0.8%)
5 (0.8%)
5 (0.8%)
4 (0.6%)
4 (0.6%)
4 (0.6%)
3 (0.5%)
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Chlorezepate
Triazolam
Ketoralac
Chlorzoxazone
Indomethacin
Chlorpheniramine
Terazosin
Olanzapine
Dronedarone
Metaxalone
Metoclopramide
Trihexyphenidyl
Oxazepam
Cyproheptadine
Hyoscyamine
Prochlorperazine

2 (0.3%)
2 (0.3%)
2 (0.3%)
2 (0.3%)
2 (0.3%)
2 (0.3%)
2 (0.3%)
2 (0.3%)
1 (0.2%)
1 (0.2%)
1 (0.2%)
1 (0.2%)
1 (0.2%)
1 (0.2%)
1 (0.2%)
1 (0.2%)
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Appendix B
Educational Session Content
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Appendix C
Educational Session Post-test
Please answer the following questions based on the educational session content.
1. The Beers Criteria are lists of inappropriate or potentially inappropriate medications for
patients age 65 and older.
True
False
2. Some medication classes included in the Beers Criteria are:
A.
B.
C.
D.

Anticholinergics
Benzodiazepines
NSAIDS
All of the above

3. What is the most common Beers medication prescribed within the system?
A. Omeprazole
B. Amiodarone
C. Diphenhydramine
D. Glyburide
4. Benzodiazepine use in elderly patients is associated with cognitive impairment, delirium,
falls, fractures, and motor vehicle crashes
True
False
5. There is a gap between patient education and Beers medication prescriptions within the
system.
True
False
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Please answer a few additional survey questions regarding the educational session.
1. How familiar were you with the Beers Criteria prior to this educational session?

2. Was this educational session helpful in refreshing your memory and/or providing you
with new information? Please explain.
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